Insulin pump based expert system

Patent metadata

Field	Value
Publication number	US-2019388015-A1
Application number	US-201916560555-A
Country	US
Kind code	A1
Filing date	Sep 4, 2019
Priority date	May 30, 2007
Publication date	Dec 26, 2019
Grant date	—

Abstract

An apparatus including a controller can determine a rate of change of a blood glucose level of a subject from blood glucose data and determine if there is a risk of the blood glucose level going high or low.

First claim

1 - 20 . (canceled)

21 . A system comprising:
a pump configured to deliver insulin; an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and a controller communicatively coupled to the pump and the input, the controller configured to:
monitor the sensor glucose data from the continuous glucose monitor;
determine a rate of change of the blood glucose level and a current glucose level of the user from the sensor glucose data;
compare the current glucose level of the user and the rate of change of the blood glucose level to a predetermined high glucose level;
determine that a correction bolus should be delivered when the current glucose level of the user is not over the predetermined high glucose level but the rate of change indicates that there is a risk of the user going over the predetermined high glucose level in the future;
automatically calculate the correction bolus; and
cause the pump to deliver the correction bolus to the user.

22 . The system of claim 21 , wherein the controller is configured to automatically deliver the correction bolus.

23 . The system of claim 21 , wherein the controller is further configured to present a recommendation to deliver the correction bolus on a user interface and to deliver the correction bolus only after receiving a confirmation in response to the recommendation.

24 . The system of claim 21 , wherein the controller is configured to determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a correction bolus should be delivered if the blood glucose level is high and increasing at a certain rate.

25 . The system of claim 21 , wherein the controller is further configured to provide a notification to the user regarding the correction bolus.

26 . The system of claim 21 , wherein the controller, the input and the pump are part of a common device.

27 . The system of claim 21 , wherein the controller and the input are part of a handheld device that is separate from the pump.

28 . A system comprising:
a pump configured to deliver insulin; an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and a controller communicatively coupled to the pump and the input, the controller configured to:
monitor the sensor glucose data from the continuous glucose monitor;
determine a rate of change of the blood glucose level of the user and a current glucose level from the sensor glucose data;
compare the current glucose level of the user and the rate of change of the blood glucose level to a target glucose level;
determine that a current insulin delivery pattern should be modified based on the current glucose level of the user and the rate of change of the blood glucose level;
automatically calculate a modification to the insulin delivery pattern; and
cause the pump to employ the modified insulin delivery pattern.

29 . The system of claim 28 , wherein the target glucose level is a predetermined high glucose level, and the controller is configured to determine that the current insulin delivery pattern should be modified when the current glucose level of the user is not over the predetermined high glucose level but the rate of change indicates that there is a risk of the user going over the predetermined high glucose level in the future.

30 . The system of claim 29 , wherein when the controller determines that the current insulin delivery pattern should be modified, the controller is configured to calculate the modification to the insulin delivery pattern by calculating an insulin correction bolus.

31 . The system of claim 28 , wherein the target glucose level is a predetermined low glucose level, and the controller is configured to determine that the current insulin delivery pattern should be modified when the current glucose level of the user is not below the predetermined high glucose level but the rate of change indicates that there is a risk of the user going below the predetermined high glucose level in the future.

32 . The system of claim 31 , wherein when the controller determines that the current insulin delivery pattern should be modified, the controller is configured to calculate the modification to the insulin delivery pattern by reducing an amount of insulin delivered.

33 . The system of claim 28 , wherein the controller comparing the current glucose level to a target glucose level includes comparing the current glucose level to a target range of glucose levels.

34 . The system of claim 28 , wherein the controller is configured to automatically deliver the modified insulin delivery pattern.

35 . The system of claim 28 , wherein the controller is further configured to present a recommendation to modify the insulin delivery pattern on a user interface and to deliver the modified insulin delivery pattern only after receiving a confirmation in response to the recommendation.

36 . The system of claim 28 , wherein the controller is further configured to provide a notification to the user regarding the modification to the insulin delivery pattern.

37 . The system of claim 28 , wherein the controller, the input and the pump are part of a common device.

38 . The system of claim 28 , wherein the controller and the input are part of a handheld device that is separate from the pump.

Assignees

• Tandem Diabetes Care Inc

Inventors

• Blomquist Michael

Classifications

• A61M2005/14208

  with a programmable infusion control system, characterised by the infusion program · CPC title

• A61B5/7475

  User input or interface means, e.g. keyboard, pointing device, joystick · CPC title

• A61B5/4839

  combined with drug delivery · CPC title

• A61B5/7275

  Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor · CPC title

• G16H40/63

  for local operation · CPC title